ClinVar Genomic variation as it relates to human health
NM_000496.3(CRYBB2):c.463C>T (p.Gln155Ter)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000496.3(CRYBB2):c.463C>T (p.Gln155Ter)
Variation ID: 16949 Accession: VCV000016949.9
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 22q11.23 22: 25231617 (GRCh38) [ NCBI UCSC ] 22: 25627584 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Oct 11, 2015 Oct 8, 2024 Oct 9, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000496.3:c.463C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000487.1:p.Gln155Ter nonsense NC_000022.11:g.25231617C>T NC_000022.10:g.25627584C>T NG_009827.1:g.16973C>T - Protein change
- Q155*
- Other names
- -
- Canonical SPDI
- NC_000022.11:25231616:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
1000 Genomes Project 30x 0.00016
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
CRYBB2 | No evidence available | No evidence available |
GRCh38 GRCh37 |
117 | 144 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Oct 9, 2023 | RCV000018458.33 | |
Likely pathogenic (1) |
no assertion criteria provided
|
Jul 29, 2016 | RCV000490780.1 | |
Pathogenic (1) |
criteria provided, single submitter
|
Dec 29, 2022 | RCV000760465.3 | |
CRYBB2-related disorder
|
Pathogenic (1) |
no assertion criteria provided
|
Nov 27, 2023 | RCV003398538.6 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Oct 09, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Cataract 3 multiple types
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV003444373.2
First in ClinVar: Feb 07, 2023 Last updated: Feb 14, 2024 |
Comment:
This sequence change creates a premature translational stop signal (p.Gln155*) in the CRYBB2 gene. While this is not anticipated to result in nonsense mediated decay, … (more)
This sequence change creates a premature translational stop signal (p.Gln155*) in the CRYBB2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 51 amino acid(s) of the CRYBB2 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with autosomal dominant congenital cataract (PMID: 9158139, 27385965, 29395391). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 16949). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(May 22, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Cataract 3 multiple types
Affected status: yes
Allele origin:
germline
|
3billion
Accession: SCV002521696.1
First in ClinVar: Jun 03, 2022 Last updated: Jun 03, 2022 |
Comment:
The variant is not observed in the gnomAD v2.1.1 dataset. Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through … (more)
The variant is not observed in the gnomAD v2.1.1 dataset. Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by more than 10%. Functional studies provide moderate evidence of the variant having a damaging effect on the gene or gene product (PMID: 15889016). The variant has been reported to co-segregate with the disease in at least 7 similarly affected relatives/individuals in at least two unrelated families (PMID: 11424921, 17234267). The variant has been reported to be associated with CRYBB2 related disorder (ClinVar ID: VCV000016949 / PMID: 9158139). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. (less)
Clinical Features:
Developmental cataract (present)
|
|
Pathogenic
(Dec 29, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000890353.2
First in ClinVar: Mar 19, 2019 Last updated: Jan 15, 2023 |
Comment:
Published functional studies demonstrate a damaging effect: reduced protein-protein interaction (Liu et al., 2005); Nonsense variant predicted to result in protein truncation, as the last … (more)
Published functional studies demonstrate a damaging effect: reduced protein-protein interaction (Liu et al., 2005); Nonsense variant predicted to result in protein truncation, as the last 51 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 11424921, 16179907, 28839118, 21245961, 9158139, 8812489, 17234267, 2240043, 10634616, 15889016, 24319337, 18449377, 28025620, 22846113, 19321936, 29395391, 27385965, 29652984, 30078984) (less)
|
|
Pathogenic
(Mar 01, 2007)
|
no assertion criteria provided
Method: literature only
|
CATARACT 3, MULTIPLE TYPES
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000038740.4
First in ClinVar: Apr 04, 2013 Last updated: Oct 11, 2015 |
Comment on evidence:
In a family segregating congenital cerulean cataract (CTRCT3; 601547) mapped to chromosome 22 by Kramer et al. (1996), Litt et al. (1997) found that affected … (more)
In a family segregating congenital cerulean cataract (CTRCT3; 601547) mapped to chromosome 22 by Kramer et al. (1996), Litt et al. (1997) found that affected individuals had a heterozygous chain-terminating mutation in CRYBB2. Of the 3 crystallin genes in the critical region, only CRYBB2 is strongly expressed in the adult lens. Hence, they chose this gene as the initial target for mutation screening. Detection of the mutation was assisted by the availability of an affected homozygote who was found to have a G-to-A transition in the antisense strand at the position of the first base of the codon normally encoding glutamine residue 155. This mutation created a stop codon that truncated the beta-B2-crystallin polypeptide by 51 residues (Q155X). The mutation also created a BfaI site, allowing convenient testing for its presence in family members. This family was originally reported by Bodker et al. (1990), who found that visual acuity was normal to mildly decreased until adult life except in 1 female, the product of affected first cousins, who was born with bilateral microphthalmia. They speculated that this represented the homozygous state. Gill et al. (2000) studied a 4-generation Swiss family with autosomal dominant Coppock-like cataract (604307) and mapped the phenotype to the 22q11.2-q13.1 region by linkage analysis. Direct cycle sequencing of exons 1 through 6 of the CRYBB2 gene identified a C-to-T transition at nucleotide 14 of exon 6, which results in an in-frame premature stop codon that truncates the beta-B2 crystallin polypeptide by 51 residues. Penetrance appeared to be complete. The study of Gill et al. (2000) demonstrated that the Coppock-like cataract phenotype is genetically heterogeneous; causative mutation had been found in the CRYGC gene (123680.0001). In affected members of a 5-generation Indian family that exhibited sutural cataract with punctate and cerulean opacities (601547), Vanita et al. (2001) identified the Q155X mutation and also found a second variant in the CRYBB2 gene, a silent 483C-T transition in exon 6 (123620.0002) that was in complete cosegregation with the phenotype. Alignment of the crystallin gene sequences showed that the Q155X and 483C-T alterations defined a fragment of at least 9 bp in the CRYBB2 mutant that were identical to the 'normal' sequence in the CRYBB2P1 pseudogene, and the fragment was flanked upstream by 28 bp and downstream by 67 bp where the gene and pseudogene are identical. Vanita et al. (2001) concluded that both variants had arisen by a gene conversion event between the CRYBB2 and its nearby pseudogene, CRYBB2P1. In affected members of a 4-generation Chilean family (ADC53) segregating autosomal dominant cataract with variable location, morphology, color, and density of the opacities (601547) among affected family members, Bateman et al. (2007) identified the Q155X mutation and the 483C-T silent polymorphism. Because the Indian family reported by Vanita et al. (2001) and this Chilean family had the same exon 6 CRYBB2 sequence but different haplotypes, Bateman et al. (2007) postulated that the alterations in each family were caused by independent gene conversion events. (less)
|
|
Likely pathogenic
(Jul 29, 2016)
|
no assertion criteria provided
Method: clinical testing
|
Developmental cataract
Affected status: yes
Allele origin:
inherited
|
Department of Ophthalmology, Flinders University
Accession: SCV000297756.1
First in ClinVar: Jun 11, 2017 Last updated: Jun 11, 2017 |
|
|
Pathogenic
(Nov 27, 2023)
|
no assertion criteria provided
Method: clinical testing
|
CRYBB2-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV004104786.3
First in ClinVar: Nov 20, 2023 Last updated: Oct 08, 2024 |
Comment:
The CRYBB2 c.463C>T variant is predicted to result in premature protein termination (p.Gln155*). This variant segregated with autosomal dominant cerulean cataract in multiple families (Litt … (more)
The CRYBB2 c.463C>T variant is predicted to result in premature protein termination (p.Gln155*). This variant segregated with autosomal dominant cerulean cataract in multiple families (Litt et al. 1997. PubMed ID: 9158139; Messina-Baas et al. 2016. PubMed ID: 27385965; Javadiyan et al. 2017. PubMed ID: 28839118; Ching et al. 2018. PubMed ID: 29395391; Zhang et al. 2018. PubMed ID: 30078984). In addition, there is evidence in the literature supporting that this variant likely arose from a gene conversion event between the CRYBB2 gene and its pseudogene, CRYBB2P1 (Vanita et al. 2001. PubMed ID: 11424921; Bateman et al. 2007. PubMed ID: 17234267). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in CRYBB2 are expected to be pathogenic. This variant is interpreted as pathogenic. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
A CRYBB2 mutation in a Taiwanese family with autosomal dominant cataract. | Ching YH | Journal of the Formosan Medical Association = Taiwan yi zhi | 2019 | PMID: 29395391 |
Whole Exome Sequencing Reveals a Mutation in CRYBB2 in a Large Mexican Family with Autosomal Dominant Pulverulent Cataract. | Messina-Baas O | Molecular syndromology | 2016 | PMID: 27385965 |
Gene conversion mutation in crystallin, beta-B2 (CRYBB2) in a Chilean family with autosomal dominant cataract. | Bateman JB | Ophthalmology | 2007 | PMID: 17234267 |
Interaction and biophysical properties of human lens Q155* betaB2-crystallin mutant. | Liu BF | Molecular vision | 2005 | PMID: 15889016 |
A unique form of autosomal dominant cataract explained by gene conversion between beta-crystallin B2 and its pseudogene. | Vanita | Journal of medical genetics | 2001 | PMID: 11424921 |
Genetic heterogeneity of the Coppock-like cataract: a mutation in CRYBB2 on chromosome 22q11.2. | Gill D | Investigative ophthalmology & visual science | 2000 | PMID: 10634616 |
Autosomal dominant cerulean cataract is associated with a chain termination mutation in the human beta-crystallin gene CRYBB2. | Litt M | Human molecular genetics | 1997 | PMID: 9158139 |
A second gene for cerulean cataracts maps to the beta crystallin region on chromosome 22. | Kramer P | Genomics | 1996 | PMID: 8812489 |
Microphthalmos in the presumed homozygous offspring of a first cousin marriage and linkage analysis of a locus in a family with autosomal dominant cerulean congenital cataracts. | Bodker FS | American journal of medical genetics | 1990 | PMID: 2240043 |
Text-mined citations for rs74315489 ...
HelpRecord last updated Oct 13, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.